Taken together, these new data open new avenues of research on N‐terminal peptides of neurogranin and on truncated peptides at Ng1_2 and Ng75_76 as potential additional AD biomarkers and for investigating the role of Ng's cleavages in the disease process of AD or in normal physiology. Here, NRGN is linked to Alzheimer disease.